Therapix Biosciences Announces Replacement of its Board of Directors
TEL AVIV, Israel, Aug. 21, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today the replacement of its board of directors. The…
Comments Off on Therapix Biosciences Announces Replacement of its Board of Directors